Anna Sureda

Research interests

Publications

• Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

  The Lancet Haematology · 2024 · https://doi.org/10.1016/s2352-3026(23)00342-3

• Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

  Blood · 2023 · https://doi.org/10.1182/blood.2023020578

• Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

  New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2312054

• Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

  Bone Marrow Transplantation · 2022 · https://doi.org/10.1038/s41409-022-01691-w

• Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

  New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2109965

• Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2206913

• Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2116133

• Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2116596

• Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

  Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.01231

• Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

  Leukemia · 2017 · https://doi.org/10.1038/leu.2017.138

• Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

  Bone Marrow Transplantation · 2016 · https://doi.org/10.1038/bmt.2016.20

• Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

  Bone Marrow Transplantation · 2015 · https://doi.org/10.1038/bmt.2015.6

• Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

  The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)60165-9

• Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

  Bone Marrow Transplantation · 2013 · https://doi.org/10.1038/bmt.2013.107

• Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation

  Blood · 2012 · https://doi.org/10.1182/blood-2012-08-448613

• High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

  Blood · 2011 · https://doi.org/10.1182/blood-2011-07-370460

• Risk score for outcome after allogeneic hematopoietic stem cell transplantation

  Cancer · 2009 · https://doi.org/10.1002/cncr.24531

• Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

  Bone Marrow Transplantation · 2009 · https://doi.org/10.1038/bmt.2009.141

• Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2008.17.9721

• Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

  Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2007.13.2415

• Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

  Bone Marrow Transplantation · 2006 · https://doi.org/10.1038/sj.bmt.1705265

• Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases

  British Journal of Haematology · 2001 · https://doi.org/10.1046/j.1365-2141.2001.03144.x

• Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation

  Blood · 1996 · https://doi.org/10.1182/blood.v88.12.4711.bloodjournal88124711

Current projects

No projects listed.